Notice of Intent to Reissue PA-20-208, Substance Use/Substance Use Disorder Dissertation Research Award
Notice Number:
NOT-DA-23-018

Key Dates

Release Date:
March 03, 2023
Estimated Publication Date of Funding Opportunity Announcement:
May 16, 2023
First Estimated Application Due Date:
June 16, 2023
Earliest Estimated Award Date:
April 16, 2024
Earliest Estimated Start Date:
April 16, 2024
Related Announcements

PA-20-208 - Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

 This Notice is to inform the research community that the National Institute on Drug Abuse (NIDA) intends to reissue the Notice of Funding Opportunity (NOFO) PA-20-208. The purpose of this NOFO is to provide dissertation awards to  rigorous doctoral candidates for up to two years for the completion of the doctoral dissertation research project. Projects should align with the NIDA Strategic Plan.   This award will facilitate the entry of investigators into the field of substance use/substance use disorder research. Applications are particularly encouraged from those who can contribute to diversifying the research workforce as described in the Notice of NIH's Interest in Diversity (NOT-OD-20-031).

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The NOFO is expected to be published in Spring 2023 with an expected application due date in Fall 2023.

This NOFO will utilize the R36 activity code. Details of the planned NOFO are provided below.

Research Initiative Details

The R36 Dissertation Research Award provides students with support to perform substance use/substance use disorder (SU/D) dissertation research. Study topics may involve basic science, developmental science, epidemiology, prevention, treatment, services research, or women and sex/gender differences. NIDA seeks to provide funds to conduct the research project to individuals who intend to subsequently establish and lead a research program related to NIDA's mission.

Funding Information

TBD

Estimated Total Funding

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Expected Number of Awards

TBD

Estimated Award Ceiling

TBD

Primary Assistance Listing Number(s)

93.279

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Email: lindsey.friend@nih.gov
Telephone:301-402-1428